Intrexon | XON - Market Capitalization


Intrexon reported $1.4B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 7M 2M Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 8.78B 236M Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Heron Therapeutics USD 238M 7M Dec/2025
Incyte USD 18.73B 660M Mar/2026
Karyopharm Therapeutics USD 1.12B 989M Jul/2026
Ligand Pharmaceuticals USD 3.98B 241M Mar/2026
MacroGenics USD 287M 103M Jul/2026
MannKind USD 757M 984M Mar/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Veracyte USD 2.57B 758M Mar/2026
Xencor USD 893M 200M Mar/2026